Covered recipient · General Payments record
ALYSSA M BORR
Eye and Vision Services Providers Optometrist
General Payments · PY2018–2024
$2,309.94
- Reported across 98 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $324.19 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Alcon Laboratories Inc | $159.45 | 9 |
| Tarsus Pharmaceuticals, Inc. | $46.25 | 2 |
| Sight Sciences, Inc. | $28.80 | 1 |
| Oyster Point Pharma, Inc. | $27.54 | 1 |
| Dompe US, Inc. | $21.77 | 1 |
| ABBVIE INC. | $21.37 | 1 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $19.01 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.37 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103350348 | CMS |
| Alcon Vision LLC | $15.50 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110667821 | CMS |
| Alcon Vision LLC | $23.85 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110667825 | CMS |
| Alcon Vision LLC | $14.13 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110667819 | CMS |
| Alcon Vision LLC | $20.22 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110667823 | CMS |
| Alcon Vision LLC | $27.15 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110667829 | CMS |
| Alcon Vision LLC | $26.57 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110667827 | CMS |
| Alcon Vision LLC | $9.10 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110667817 | CMS |
| Alcon Vision LLC | $2.13 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110826774 | CMS |
| Alcon Vision LLC | $20.80 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110826776 | CMS |
| Dompe US, Inc. | $21.77 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151396857 | CMS |
| Oyster Point Pharma, Inc. | $27.54 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147410843 | CMS |
| Sight Sciences, Inc. | $28.80 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151934513 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $19.01 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152123297 | CMS |
| Tarsus Pharmaceuticals, Inc. | $27.66 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139083943 | CMS |
| Tarsus Pharmaceuticals, Inc. | $18.59 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139083947 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.